Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07124533Phase 3Not yet recruiting
Phase 3, randomised trial of Denttabs in gingivitis and dental caries (2 arms), sponsored by Loma Linda University. Primary endpoints: Plaque Index at 6 weeks and Gingival Index at 6 weeks. Planned start Dec 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07124533.